European Journal of Neurology

Article	Citations
Basal ganglia matter	223
Comparative analysis of dimethyl fumarate and teriflunomide in relapsing–remitting multiple sclerosis	128
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift	123
What biological markers could be used for diagnosis and monitoring of nitrous oxide abuse?	114
Thank you to our peer reviewers in 2023	113
COVID‐19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark	96
Possible benefit of second intravenous immunoglobulin course in Guillain−Barré syndrome patients with potentially poor prognosis	87
Benefits of influenza vaccine on stroke beyond preventing infection: Paradigm change or sheer bias?	86
Special Sessions	82
Machine‐learning‐derived heart and brain age are independently associated with cognition	80
Issue Information	78
European Journal of Neurology will flip to open access in January 2024	77
Issue Information	73
Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study	71
Spinal muscular atrophy: are small sensory fibres involved?	71
Enhancing multisensory rehabilitation of visual field defects with transcranial direct current stimulation: A randomized clinical trial	66
Dorsolateral pontine lesions produce distinct ocular motor abnormalities with anatomical correlations	55
Issue Information	54
Predictors of affective disturbances and cognitive impairment following small spontaneous supratentorial intracerebral hemorrhage	53
Complement activation by IgM autoantibodies linked to immune‐mediated neuropathies depends on C2	52
A roadmap toward promoting and improving brain health in Europe and closing the awareness and funding gap	51
Serum neurofilament light chain predicts disease severity in axonal variants of acute immune neuropathies: A retrospective monocentric cohort study	51
Development and validation of an electronic Symbol‐Digit Modalities Test for remote monitoring of people with multiple sclerosis	50
Small fiber neuropathy associated with COVID‐19 infection and vaccination: A prospective case–control study	48
Comparison of different surgical strategies for cervical dystonia: Evidence from Bayesian network analysis	47

Cost‐utility analysis of a coadjutant telemedicine intervention for fall prevention in Parkinson's disease	47
Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation	47
The presence and burden of cognitive issues: discordance between the perception of neurologists and people living with multiple sclerosis	45
Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study	45
Postural control in episodic ataxia type 2: no evidence for increased vestibular excitability	45
Assessment of the available evidence for the use of 7‐Tesla (T) magnetic resonance imaging (MRI) in neurological and musculoskeletal disorders, with comparison to 3‐T	45
Prognostic Value of Signal Abnormalities on Brain MRI in Post‐Anoxic Super‐Refractory Status Epilepticus: A Single‐Center Retrospective Study	44
Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease	41
The European Academy of Neurology NeuroCOVID‐19 Task Force: A lesson for the future	40
Lyme neuroborreliosis in Japan: Borrelia burgdorferi sensu lato as a cause of meningitis of previously undetermined etiology in hospitalized patients outside of the island of Hokkaido, 2010–202	40
Neglected outcomes of cerebrovascular disorders in neuromuscular diseases	39
Paramagnetic rim lesions are associated with inner retinal layer thinning and progression independent of relapse activity in multiple sclerosis	39
A common marker of affect recognition dysfunction in the FTD spectrum of disorders	39
Brain neurovascular coupling in amyotrophic lateral sclerosis: Correlations with disease progression and cognitive impairment	39
Central nervous system crystal‐storing histiocytosis: A case report and literature review	37
Mild cognitive impairment and early Alzheimer's disease eligibility for disease modification therapies in a tertiary centre for cognitive disorders: A simultaneous real‐word study on aducanumab and le	37
Functional connectivity and metabolic brain alterations in sleepwalkers	35
Diagnostic added value of interictal magnetic source imaging in presurgical evaluation of persons with epilepsy: A prospective blinded study	34
Blood pressure variability and functional outcome after decompressive hemicraniectomy in malignant middle cerebral artery infarction	34
CORRIGENDUM	34
Lower serum uric acid to serum creatinine ratio as a predictor of poor functional outcome after mechanical thrombectomy in acute ischaemic stroke	33
Mechanical thrombectomy in young patients with large vessel occlusion‐related ischemic stroke: Data from the Italian Registry of Endovascular Treatment in Acute Stroke	33
Risk of a first clinical diagnosis of central nervous system demyelination in relation to human herpesviruses in the context of Epstein–Barr virus	33
Pulmonary arteriovenous malformations in patients with previous brain abscess: a cross‐sectional population‐based study	32
Blood pressure variability in acute stroke: Risk factors and association with functional outcomes at 1 month	32
Clinical variables contributing to the identification of biologically defined subgroups within cognitively unimpaired and mild cognitive impairment individuals	32
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study	32
Reply to “Serum neurofilament light chain and small fiber neuropathy: Every cloud has a silver lining” by D. Plantone and G. Primiano	32
Effect of APOE ε4 genotype on amyloid‐β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment	31
Relationship between primary stroke center volume and time to endovascular thrombectomy in acute ischemic stroke	31
Effects of blood lipids and lipid‐modifying drugs on intracranial aneurysms	31
Cost‐effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health‐related quality of life	31
Association of the COVID‐19 outbreak with acute stroke care in Switzerland	31
Mirror therapy for unilateral neglect after stroke: A systematic review	30
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross‐sectional and longitudinal study	30
Anti‐seizure medication response and the glymphatic system in patients with focal epilepsy	30
Elevated serum anti‐Saccharomyces cerevisiae antibody accompanied by gut mycobiota dysbiosis as a biomarker of diagnosis in patients with de novo Parkinson disease	30
CCR5‐Δ32polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients	30
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report	30
Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late‐onset cerebellar ataxia	30
Long‐term consequences of subarachnoid haemorrhage: Is it time for new strategies?	29
	29
Sporadic Creutzfeldt–Jakob disease presenting as epilepsia partialis continua and non‐ictal nystagmus	27
PLEKHG5: Merging phenotypes and disease mechanisms in Charcot‐Marie‐Tooth neuropathy and lower motor neuron disease	27
Reply to: Minimal detectable change and minimal clinically important differences in spinal muscular atrophy patients	27
Undergraduate neurology training in the inpatient and outpatient setting: How do they differ?	27
Issue Information	27
One year later …	27
Issue Information	27
Letter to the Editor: “Correlation between total homocysteine and cerebral small vessel disease: A Mendelian randomization study”	26

From bedside to bench and back	26
MAPT Q336H mutation: Intrafamilial phenotypic heterogeneity in a new Italian family	26
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis	25
Distinct disease trajectories in frontotemporal dementia–motor neuron disease and behavioural variant frontotemporal dementia: A longitudinal study	25
Clinical and electrophysiological characteristics of women with X‐linked Charcot–Marie–Tooth disease	25
Circulating folate concentrations and the risk of mild cognitive impairment: A prospective study on the older Chinese population without folic acid fortification	24
Dysphagia in primary progressive aphasia: Clinical predictors and neuroanatomical basis	24
Comorbidity patterns in people with multiple sclerosis: A latent class analysis of the Australian Multiple Sclerosis Longitudinal Study	24
Issue Information	24
Headaches and facial pain attributed to SARS‐CoV‐2 infection and vaccination: a systematic review	24
Response to Geroin et al.: Tapping into the mechanisms of abnormal functional postural control	24
Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter study	24
Iatrogenic cerebral amyloid angiopathy: An illustrative case of a newly introduced disease	24
Thymectomy in myasthenia gravis: “The real world” experience beyond studies	23
Prioritization process for European Academy of Neurology clinical practice guidelines	23
Electroencephalography functional connectivity—A biomarker for painful polyneuropathy	23
Clinical value of Young Stroke Questionnaire	23
The paradigm shift in long‐term treatments for migraine prevention	23
Focused Workshops	23
The amnestic syndrome of posterior cerebral artery infarction	23
Cervical and thoracic spinal cord gray matter atrophy is associated with disability in patients with amyotrophic lateral sclerosis	23
Proteinuria is a key to suspect autoimmune nodopathies	22
Small intracranial aneurysms of the anterior circulation: A negligible risk?	22
Prospective longitudinal study on prognostic factors of visual recovery and structural change after a first episode of optic neuritis	22
Issue Information	22
Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels	22
Blood–brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease	22
Ambient air pollution, covert cerebrovascular disease and cognition: results from the ISSYS study	22
Cross‐sectional study on patients' understanding and views of the informed consent procedure of a secondary stroke prevention trial	22
Association between striatal amyloid deposition and motor prognosis in Parkinson's disease	22
Undiagnosed major risk factors in acute ischaemic stroke patients: frequency, profile, stroke mechanisms and outcome	21
False‐negative tests in Huntington's disease: A new variant within primer hybridization site	21
Etiologic distribution of isolated trochlear palsy: Analysis of 1020 patients and literature review	21
Issue Information	21
The COVID‐19 pandemic and neurology: A survey on previous and continued restrictions for clinical practice, curricular training, and health economics	21
Central nervous system tumours among users of vaginal oestradiol tablets: A nationwide population‐based study	21
Circle of Willis variants and their association with outcome in patients with middle cerebral artery‐M1‐occlusion stroke	21
Adaption and preliminary validation of the Addenbrooke's Cognitive Examination‐III as a screening test for mild cognitive impairment and dementia in hearing‐impaired individuals	21
Topical Symposia	21
Hearing impairment and development of parkinsonism and possible rapid eye movement sleep behaviour disorder: A CLSA prospective population‐based study	21
Impact of diabetes mellitus on the respiratory function of amyotrophic lateral sclerosis patients	21
Cerebral venous sinus thrombosis associated with COVID‐19 vaccine‐induced thrombocytopenia: Improvement in mortality rate over time	21
Minor stroke in large vessel occlusion: A matched analysis of patients from the German Stroke Registry–Endovascular Treatment (GSR‐ET) and patients from the Safe Implementation of Treatments in Stroke	21
How to approach a neurogenetics diagnosis in different European countries: The European Academy of Neurology Neurogenetics Panel survey	21
Investigating paraneoplastic aquaporin‐4‐IgG‐seropositive neuromyelitis optica spectrum disorder through a data‐driven approach	21
Determinants of adherence to post‐stroke/transient ischemic attack secondary prevention medications: A cohort study	21
Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome	20
Analysis of co‐medication in people with dementia	20
Modulatory effects of vitamin D on IL ‐33/ ST2 immune axis in Guillain–Barré syndrome…quo vadis?	20
Ambulatory blood pressure and drug treatment for orthostatic hypotension as predictors of mortality in patients with multiple system atrophy	20
Temporal trends and outcomes in acute ischaemic stroke patients with a current or historical diagnosis of cancer	20
Sleep disorders and increased risk of dementia	20
Neuropathic pain ‐ Still a challenge to assess	20
	19
ePresentations	19
Association of cholesterol level with dopamine loss and motor deficits in Parkinson disease: A cross‐sectional study	19
Seizures—the second most frequent neurological emergency	19
Clinical evidence in ischemic stroke: Where we have gone so far and hopes for the future	19
	19
Association of HMOX‐1 with sporadic Alzheimer’s disease in southern Han Chinese	19
Did Martin Luther suffer from vestibular migraine?	19
Lessons from the past to understand the future	19
Eptinezumab improved patient‐reported outcomes and quality of life in patients with migraine and prior preventive treatment failures	19
Symposia	19
Partial and nonresponders to onabotulinumtoxinA can benefit from anti‐CGRP monoclonal antibodies preventive treatment: A real‐world evidence study	18
Reply to the letter from Gazulla et al.	18
Autoantibody levels as biomarkers of disease activity in the management of myasthenia gravis	18
Issue Information	18
Diagnostic accuracy of cerebrospinal fluid biomarkers for the differential diagnosis of sporadic Creutzfeldt–Jakob disease: a (network) meta‐analysis	18
Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients	18
Cardiac sources of cerebral embolism in people with migraine	18
Late‐breaking Abstracts	18
Adult onset epilepsy incidence in Finland over 34 years: A nationwide registry study	18
Chronic severe methanol intoxication after repeated mask cleansing due to fear of COVID‐19: A new risk of coronaphobia	18
Structural correlations between brain magnetic resonance image‐derived phenotypes and retinal neuroanatomy	18
Clinical correlates of fear of falling in progressive supranuclear palsy and multiple system atrophy	17
Independent effects of amyloid and vascular markers on long‐term functional outcomes: An 8‐year longitudinal study of subcortical vascular cognitive impairment	17
Acute onset movement disorders in diabetes mellitus: A clinical series of 59 patients	17
Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study	17
Issue Information	17

Tumefactive multiple sclerosis or inflammatory demyelinating disease with large lesions?	17
Prevalence and clinical profiles of anti‐myelin‐associated glycoprotein neuropathy in Japan: A nationwide survey study of 133 patients	17
Large disparities in 28‐day case fatality by stroke subtype: data from a French stroke registry between 2008 and 2017	17
Non‐demyelinating disorders mimicking and misdiagnosed asNMOSD:a literature review	17
I spy with my little eye: The detection of changes in emotional faces and the influence of facial feedback in Parkinson disease	17
Movement disorders following mechanical thrombectomy resulting in ischemic lesions of the basal ganglia: An emerging clinical entity	17
ePosters	17
Characterization and quantification of alcohol‐related polyneuropathy by magnetic resonance neurography	17
Impact of the coronavirus disease 2019 pandemic on stroke teleconsultations in Germany in the first half of 2020	17
Guillain–Barré syndrome following influenza vaccination: A 15‐year nationwide population‐based case–control study	17
Melatonin's role in managing nocturia in Parkinson disease: A critical examination of recent studies	17
Associations of Life's Simple 7 with cerebral white matter hyperintensities and microstructural integrity: UK Biobank cohort study	17
Efficacy and safety of botulinum toxin for treating sialorrhea: A systematic review and meta‐analysis	17
The location of intraparenchymal bleeding determines functional outcome after spontaneous subarachnoid hemorrhage	17
Prevalence of disability improvement in relapsing–remitting multiple sclerosis patients treated with cladribine tablets	16
Movement disorders in valine métabolism diseases caused by HIBCH and ECHS1 deficiencies	16
A model for interrogating the clinico‐radiological paradox in multiple sclerosis: Internuclear ophthalmoplegia	16
Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study	16
Ultraearly thrombolysis by an anesthesiologist in a mobile stroke unit: A prospective, controlled intervention study	16
Neuronal intranuclear inclusion disease tremor‐dominant subtype: A mimicker of essential tremor	16
Sporadic Creutzfeldt–Jakob disease with extremely long 14‐year survival period	16
Global trends in symptomatic medication use against dementia in 66 countries/regions from 2008 to 2018	16
Prevalence of acute dizziness and vertigo in cortical stroke	16
Brain magnetic resonance imaging lesion load at diagnosis, severity at onset and outcomes in Susac syndrome: A prospective cohort study	16
Chronic inflammatory demyelinating polyradiculoneuropathy‐associated tremor: Phenotype and pathogenesis	16
Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein‐a	16
Self‐awareness in multiple sclerosis: Relationships with executive functions and affect	16
Predictors of malnutrition risk in neurodegenerative diseases: The role of swallowing function	16
Modifiable vascular risk factors in patients with cerebral and spinal cavernous malformations: a complete 10‐year follow‐up study	16
TheCYP24A1gene variant rs2762943 is associated with low serum 1,25‐dihydroxyvitamin D levels in multiple sclerosis patients	16
Impact of the metabolic syndrome on peripheral nerve structure and function in type 2 diabetes	16
Greater small nerve fibre damage in the skin and cornea of type 1 diabetic patients with painful compared to painless diabetic neuropathy	16
Antiganglioside antibody frequency in routine clinical care settings	16
Risk factors for the progression of motoric cognitive risk syndrome to dementia: Retrospective cohort analysis of two populations	16
COVID‐19 and ischemic stroke	16
COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition	15
The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective	15
Systemic immune response against the oral pathogens Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans is associated with the formation and rupture of intracranial aneury	15
Real‐world persistence of multiple sclerosis disease‐modifying therapies	15
Management of seizures in patients with primary mitochondrial diseases: consensus statement from the InterERNs Mitochondrial Working Group	15
Functional connectivity in Lewy body disease with visual hallucinations	15
Association between serum secretory phospholipase A2 and risk of ischaemic stroke	15
Central nervous system atrophy predicts future dynamics of disability progression in a real‐world multiple sclerosis cohort	15
Sex differences in clinical characteristics of migraine and its burden: a population‐based study	15
Issue Information	15
Reply to the letter: Headaches during/after SARS‐CoV‐2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and M	15
Is the bedside head impulse test useful in emergency decision making for nonexpert routine clinical practice?	15
Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosis	15
Electrophysiological, histopathological, and biochemical evaluation of the protective effect of probiotic supplementation against pentylenetetrazole‐induced seizures in rats	15
Anti‐CD20 therapy for multiple sclerosis‐associated uveitis: A case series	15
Immunity and Gilles de la Tourette syndrome: A systematic review and meta‐analysis of evidence for immune implications in Tourette syndrome	15
Factors affecting the topography of nitrous oxide‐induced neurological complications	15
Optical coherence tomography assessment of disease activity in cryopyrin‐associated periodic syndrome	15
Severity of in vivo corticospinal tract degeneration is associated with survival in amyotrophic lateral sclerosis: a longitudinal, multicohort study	15
Identification of UBA1 as the causative gene of an X‐linked non‐Kennedy spinal–bulbar muscular atrophy	14
Correlation between patient‐reported manual ability and three objective measures of upper limb function in people with multiple sclerosis	14
Progressive conus medullaris lesions are suggestive of intravascular large B‐cell lymphoma	14
Toxoplasma gondii and multiple sclerosis: A systematic review and meta‐analysis	14
Predicting functional outcome in patients with acute brainstem infarction using deep neuroimaging features	14
Reduction in cerebral oxygen metabolism in subcortical regions may be a biomarker of cognitive decline in people living with human immunodeficiency virus	14
Sensitized rotatory motion perception and increased susceptibility to motion sickness in vestibular migraine: A cross‐sectional study	14
Serum neurofilament light chain cut‐off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis	14
Predictors for the development of neurological immune‐related adverse events of immune checkpoint inhibitors and impact on mortality	14
Relapse‐associated worsening in a real‐life multiple sclerosis cohort: the role of age and pyramidal phenotype	14
Discriminative value of different combinations of tests to detect unilateral neglect in patients with right hemisphere damage	14
The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosis	14
Early apathetic, but not depressive, symptoms are associated with poor outcome after stroke	14
Association of peripapillary hyper‐reflective ovoid masslike structures and disease duration in primary progressive multiple sclerosis	14
Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravis	14
Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis?	14
Outcome of Guillain–Barré syndrome following intravenous immunoglobulin compared to natural course	14
Efficacy and safety of pharmacological treatments for Lyme neuroborreliosis: An updated systematic review	14
Prevalence and clinical aspects of obstructive sleep apnea in Parkinson disease: A meta‐analysis	14
Caveolinopathy: Clinical, histological, and muscle imaging features and follow‐up in a multicenter retrospective cohort	14
Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: Identifying relevant outcome factors	14
Genetic screening for hereditary transthyretin amyloidosis with polyneuropathy in western Sicily: Two years of experience in a neurological clinic	14
Ictal apnea: A prospective monocentric study in patients with epilepsy	14
Neural correlates of self‐awareness of cognitive deficits in non‐demented patients with Parkinson's disease	14
Neurological complications during the Omicron COVID‐19 wave in China: A cohort study	14
Risk of aspiration pneumonia and hospital mortality in Parkinson disease: A systematic review and meta‐analysis	13
Correlations between serotonin impairments and clinical indices in multiple system atrophy	13
Neuromuscular ultrasound in combination with nerve conduction studies helps identify inflammatory motor neuropathies from lower motor neuron syndromes	13
Basal ganglia ischaemic infarction after thrombectomy: cognitive impairment at acute stage	13
Quantitative magnetic resonance imaging of the brachial plexus shows specific changes in nerve architecture in chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy and motor	13
Characteristics and temporal evolution of asymptomatic diffusion‐weighted imaging lesions in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (<	13
Cholinergic dysfunction in isolated rapid eye movement sleep behaviour disorder links to impending phenoconversion	13
One‐year cognitive follow‐up of COVID‐19 hospitalized patients	13
Endovascular therapy versus no endovascular therapy in patients receiving best medical management for acute isolated occlusion of the posterior cerebral artery: A systematic review andmeta‐analys	13
Risk of disease relapse, safety and tolerability of SARS‐CoV‐2 vaccination in patients with chronic inflammatory neuropathies	13
Plasma phosphorylated tau181 outperforms [18F] fluorodeoxyglucose positron emission tomography in the identification of early Alzheimer disease	13
Real‐world smartphone data can trace the behavioural impact of epilepsy: A case study	13
Elevated serum circulating cell‐free mitochondrial DNA in amyotrophic lateral sclerosis	13
Diagnostic delay in amyotrophic lateral sclerosis	13
	13
The decline in stroke hospitalization due to COVID‐19 is unrelated to COVID‐19 intensity	13